{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:29:50Z","timestamp":1784582990965,"version":"3.55.0"},"reference-count":32,"publisher":"Bioscientifica","issue":"3","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":3481,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background: Selenium (Se) is a trace element that plays key roles in thyroid physiology. Se deficiency is associated with increased risk of thyroid disease. Some evidence suggests that Se supplementation may be beneficial in autoimmune thyroid disease (either hypo- or hyperthyroidism). Objectives: We sought to examine the use of Se in daily clinical practice among Italian endocrinologists. Methods: Members of the Associazione Medici Endocrinologi (AME) were invited to participate in a web-based survey investigating the use of Se in different clinical conditions. Results: A total of 815 individuals (43.2% of AME members) participated in the survey, 778 of whom completed all of the sections. Among these respondents, 85.2% considered using Se for thyroid disease (58.1% rarely\/occasionally and 27.1% often\/always), and 79.4% prescribed Se for chronic autoimmune thyroiditis (AIT) (39.1% sometimes and 40.3% often\/always). About two thirds of the respondents considered Se use in cases of subclinical autoimmune hypothyroidism, and about 40% had suggested Se use for patients with AIT who were planning pregnancy or already pregnant. About one fourth of the respondents had used Se for mild Graves' orbitopathy. Regarding the suggested daily dosage of Se, 60% of the respondents answered 100-200 \u00b5g, 20-30% recommended &amp;lt;100 \u00b5g, and 10-20% recommended &amp;gt;200 \u00b5g. Conclusions: Se use is widely considered in daily clinical practice. Moreover, Se supplementation is often used or suggested for purposes extending beyond those supported by evidence-based medicine. Ongoing studies will better clarify how Se treatment can be properly utilized in thyroid disease management.<\/jats:p>","DOI":"10.1159\/000447667","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T17:01:22Z","timestamp":1470762082000},"page":"164-170","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":43,"title":["A 2016 Italian Survey about the Clinical Use of Selenium in Thyroid Disease"],"prefix":"10.1530","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9282-4530","authenticated-orcid":false,"given":"Roberto","family":"Negro","sequence":"first","affiliation":[{"name":"1Division of Endocrinology, \u2018V. Fazzi' Hospital, Lecce"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Attanasio","sequence":"additional","affiliation":[{"name":"2Endocrinology Service, Galeazzi Institute IRCCS, Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Grimaldi","sequence":"additional","affiliation":[{"name":"3Endocrinology and Metabolic Disease Unit, Azienda Ospedaliero-Universitaria \u2018S. Maria della Misericordia', Udine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6568-8588","authenticated-orcid":false,"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[{"name":"4Department of Clinical and Experimental Medicine, University of Pisa, Pisa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Guglielmi","sequence":"additional","affiliation":[{"name":"5Department of Endocrinology, Regina Apostolorum Hospital, Albano Laziale, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Papini","sequence":"additional","affiliation":[{"name":"5Department of Endocrinology, Regina Apostolorum Hospital, Albano Laziale, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2016,8,6]]},"reference":[{"key":"2026070712475065500_ref1","doi-asserted-by":"crossref","unstructured":"K\u00f6hrle J, Jakob F, Contempr\u00e9 B, Dumont JE: Selenium, the thyroid, and the endocrine system. Endocr Rev 2005;26:944-984.10.1210\/er.2001-003416174820","DOI":"10.1210\/er.2001-0034"},{"key":"2026070712475065500_ref2","doi-asserted-by":"crossref","unstructured":"Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guig\u00f3 R, Gladyshev VN: Characterization of mammalian selenoproteomes. Science 2003;300:1439-1443.10.1126\/science.108351612775843","DOI":"10.1126\/science.1083516"},{"key":"2026070712475065500_ref3","doi-asserted-by":"crossref","unstructured":"Zimmermann MB, K\u00f6hrle J: The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid 2002;12:867-878.10.1089\/10507250276101649412487769","DOI":"10.1089\/105072502761016494"},{"key":"2026070712475065500_ref4","doi-asserted-by":"crossref","unstructured":"Chiu-Ugalde J, Wirth EK, Klein MO, Sapin R, Fradejas-Villar N, Renko K, Schomburg L, K\u00f6hrle J, Schweizer U: Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells. Antioxid Redox Signal 2012;17:902-913.10.1089\/ars.2011.405522369680","DOI":"10.1089\/ars.2011.4055"},{"key":"2026070712475065500_ref5","doi-asserted-by":"crossref","unstructured":"Wu Q, Rayman MP, Lv H, Schomburg L, Cui B, Gao C, Chen P, Zhuang G, Zhang Z, Peng X, Li H, Zhao Y, He X, Zeng G, Qin F, Hou P, Shi B: Low population selenium status is associated with increased prevalence of thyroid disease. J Clin Endocrinol Metab 2015;100:4037-4047.10.1210\/jc.2015-222226305620","DOI":"10.1210\/jc.2015-2222"},{"key":"2026070712475065500_ref6","doi-asserted-by":"crossref","unstructured":"G\u00e4rtner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW: Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 2002;87:1687-1691.10.1210\/jcem.87.4.842111932302","DOI":"10.1210\/jcem.87.4.8421"},{"key":"2026070712475065500_ref7","doi-asserted-by":"crossref","unstructured":"Duntas LH, Mantzou E, Koutras DA: Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol 2003;148:389-393.10.1530\/eje.0.148038912656658","DOI":"10.1530\/eje.0.1480389"},{"key":"2026070712475065500_ref8","doi-asserted-by":"crossref","unstructured":"Mazokopakis EE, Papadakis JA, Papadomanolaki MG, Batistakis AG, Giannakopoulos TG, Protopapadakis EE, Ganotakis ES: Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto's thyroiditis. Thyroid 2007;17:609-612.10.1089\/thy.2007.004017696828","DOI":"10.1089\/thy.2007.0040"},{"key":"2026070712475065500_ref9","doi-asserted-by":"crossref","unstructured":"Eskes SA, Endert E, Fliers E, Birnie E, Hollenbach B, Schomburg L, K\u00f6hrle J, Wiersinga WM: Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies. Clin Endocrinol (Oxf) 2014;80:444-451.10.1111\/cen.1228423844613","DOI":"10.1111\/cen.12284"},{"key":"2026070712475065500_ref10","doi-asserted-by":"crossref","unstructured":"Bonfig W, G\u00e4rtner R, Schmidt H: Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis. ScientificWorldJournal 2010;10:990-996.10.1100\/tsw.2010.9120526530","DOI":"10.1100\/tsw.2010.91"},{"key":"2026070712475065500_ref11","doi-asserted-by":"crossref","unstructured":"Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H: The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007;92:1263-1268.10.1210\/jc.2006-182117284630","DOI":"10.1210\/jc.2006-1821"},{"key":"2026070712475065500_ref12","doi-asserted-by":"crossref","unstructured":"Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, Altea MA, Nardi M, Pitz S, Boboridis K, Sivelli P, von Arx G, Mourits MP, Baldeschi L, Bencivelli W, Wiersinga W; European Group on Graves' Orbitopathy: Selenium and the course of mild Graves' orbitopathy. N Engl J Med 2011;364:1920-1931.10.1056\/NEJMoa101298521591944","DOI":"10.1056\/NEJMoa1012985"},{"key":"2026070712475065500_ref13","doi-asserted-by":"crossref","unstructured":"Toulis KA, Anastasilakis AD, Tzellos TG, Goulis DG, Kouvelas D: Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis. Thyroid 2010;20:1163-1173.10.1089\/thy.2009.035120883174","DOI":"10.1089\/thy.2009.0351"},{"key":"2026070712475065500_ref14","doi-asserted-by":"crossref","unstructured":"van Zuuren EJ, Albusta AY, Fedorowicz Z, Carter B, Pijl H: Selenium supplementation for Hashimoto's thyroiditis: summary of a Cochrane Systematic Review. Eur Thyroid J 2014;3:25-31.10.1159\/00035604024847462","DOI":"10.1159\/000356040"},{"key":"2026070712475065500_ref15","doi-asserted-by":"crossref","unstructured":"Rayman MP, Thompson AJ, Bekaert B, Catterick J, Galassini R, Hall E, Warren-Perry M, Beckett GJ: Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom. Am J Clin Nutr 2008;87:370-378.18258627","DOI":"10.1093\/ajcn\/87.2.370"},{"key":"2026070712475065500_ref16","doi-asserted-by":"crossref","unstructured":"Winther KH, Watt T, Bj\u00f8rner JB, Cramon P, Feldt-Rasmussen U, Gluud C, Gram J, Groenvold M, Heged\u00fcs L, Knudsen N, Rasmussen \u00c5K, Bonnema SJ: The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial. Trials 2014;15:115.10.1186\/1745-6215-15-11524716668","DOI":"10.1186\/1745-6215-15-115"},{"key":"2026070712475065500_ref17","doi-asserted-by":"crossref","unstructured":"Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A: Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 2011;342:d2616.10.1136\/bmj.d261621558126","DOI":"10.1136\/bmj.d2616"},{"key":"2026070712475065500_ref18","doi-asserted-by":"crossref","unstructured":"Krassas GE: Thyroid disease and female reproduction. Fertil Steril 2000;74:1063-1070.10.1016\/S0015-0282(00)01589-211119728","DOI":"10.1016\/S0015-0282(00)01589-2"},{"key":"2026070712475065500_ref19","doi-asserted-by":"crossref","unstructured":"Mao J, Pop VJ, Bath SC, Vader HL, Redman CW, Rayman MP: Effect of low-dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-to-moderate iodine deficiency. Eur J Nutr 2016;55:55-61.10.1007\/s00394-014-0822-925524327","DOI":"10.1007\/s00394-014-0822-9"},{"key":"2026070712475065500_ref20","unstructured":"Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Selenium (Update). Atlanta, Public Health Service, Department of Health and Human Services, 1996."},{"key":"2026070712475065500_ref21","doi-asserted-by":"crossref","unstructured":"Kupka R, Mugusi F, Aboud S, Msamanga GI, Finkelstein JL, Spiegelman D, Fawzi WW: Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes. Am J Clin Nutr 2008;87:1802-1808.18541571","DOI":"10.1093\/ajcn\/87.6.1802"},{"key":"2026070712475065500_ref22","doi-asserted-by":"crossref","unstructured":"Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S, Wiersinga W; American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum: Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011;21:1081-1125.10.1089\/thy.2011.008721787128","DOI":"10.1089\/thy.2011.0087"},{"key":"2026070712475065500_ref23","doi-asserted-by":"crossref","unstructured":"De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, Eastman CJ, Lazarus JH, Luton D, Mandel SJ, Mestman J, Rovet J, Sullivan S: Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012;97:2543-2565.10.1210\/jc.2011-280322869843","DOI":"10.1210\/jc.2011-2803"},{"key":"2026070712475065500_ref24","doi-asserted-by":"crossref","unstructured":"Marcocci C, Leo M, Altea MA: Oxidative stress in Graves' disease. Eur Thyroid J 2012;1:80-87.10.1159\/00033797624783001","DOI":"10.1159\/000337976"},{"key":"2026070712475065500_ref25","doi-asserted-by":"crossref","unstructured":"B\u00fclow Pedersen I, Knudsen N, Carl\u00e9 A, Schomburg L, K\u00f6hrle J, J\u00f8rgensen T, Rasmussen LB, Ovesen L, Laurberg P: Serum selenium is low in newly diagnosed Graves' disease: a population-based study. Clin Endocrinol (Oxf) 2013;79:584-590.10.1111\/cen.1218523448365","DOI":"10.1111\/cen.12185"},{"key":"2026070712475065500_ref26","doi-asserted-by":"crossref","unstructured":"Khong JJ, Goldstein RF, Sanders KM, Schneider H, Pope J, Burdon KP, Craig JE, Ebeling PR: Serum selenium status in Graves' disease with and without orbitopathy: a case-control study. Clin Endocrinol (Oxf) 2014;80:905-910.10.1111\/cen.1239224372054","DOI":"10.1111\/cen.12392"},{"key":"2026070712475065500_ref27","doi-asserted-by":"crossref","unstructured":"Dehina N, Hofmann PJ, Behrends T, Eckstein A, Schomburg L: Lack of association between selenium status and disease severity and activity in patients with Graves' ophthalmopathy. Eur Thyroid J 2016;5:57-64.10.1159\/00044244027099840","DOI":"10.1159\/000442440"},{"key":"2026070712475065500_ref28","doi-asserted-by":"crossref","unstructured":"Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, Perros P, Salvi M, Wiersinga WM; European Group on Graves' Orbitopathy (EUGOGO): The 2016 European Thyroid Association\/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy. Eur Thyroid J 2016;5:9-26.10.1159\/00044382827099835","DOI":"10.1159\/000443828"},{"key":"2026070712475065500_ref29","doi-asserted-by":"crossref","unstructured":"Thomson CD: Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr 2004;58:391-402.10.1038\/sj.ejcn.160180014985676","DOI":"10.1038\/sj.ejcn.1601800"},{"key":"2026070712475065500_ref30","doi-asserted-by":"crossref","unstructured":"Pilli T, Cantara S, Schomburg L, Cenci V, Cardinale S, Heid EC, K\u00fchn EC, Cevenini G, Sestini F, Fioravanti C, D'Hauw G, Pacini F: IFN\u03b3-inducible chemokines decrease upon selenomethionine supplementation in women with euthyroid autoimmune thyroiditis: comparison between two doses of selenomethionine (80 or 160 \u03bcg) versus placebo. Eur Thyroid J 2015;4:226-233.10.1159\/00043958926835425","DOI":"10.1159\/000439589"},{"key":"2026070712475065500_ref31","doi-asserted-by":"crossref","unstructured":"Santos LR, Dur\u00e3es C, Mendes A, Prazeres H, Alvelos MI, Moreira CS, Canedo P, Esteves C, Neves C, Carvalho D, Sobrinho-Sim\u00f5es M, Soares P: A polymorphism in the promoter region of the selenoprotein S gene (SEPS1) contributes to Hashimoto's thyroiditis susceptibility. J Clin Endocrinol Metab 2014;99:E719-E723.10.1210\/jc.2013-353924471570","DOI":"10.1210\/jc.2013-3539"},{"key":"2026070712475065500_ref32","doi-asserted-by":"crossref","unstructured":"Watt T, Cramon P, Bjorner JB, Bonnema SJ, Feldt-Rasmussen U, Gluud C, Gram J, Hansen JL, Heged\u00fcs L, Knudsen N, Bach-Mortensen P, Nols\u00f8e R, Nygaard B, Pociot F, Skoog M, Winkel P, Rasmussen AK: Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial. Trials 2013;14:119.10.1186\/1745-6215-14-1123302232","DOI":"10.1186\/1745-6215-14-119"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/447667","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/5\/3\/164\/29689\/etj447667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/5\/3\/164\/29689\/etj447667.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:11:11Z","timestamp":1783444271000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/5\/3\/164\/4014\/A-2016-Italian-Survey-about-the-Clinical-Use-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000447667","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8,6]]}}}